Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
The stock roughly doubled following renewed investor optimism after a cancer-vaccine trial outcome, after which William Blair upgraded Moderna’s shares.
THE APEX TIMES
THE APEX TIMES
A report highlights growing pressure on Nvidia as hyperscalers like Google pursue in-house chips aimed at lowering the cost of running artificial intelligence workloads.
THE APEX TIMES
The companies said a late-stage study of an experimental skin-cancer treatment produced positive phase 3 findings, driving a steep one-day move in Moderna’s stock.
THE APEX TIMES
A retreat in Treasury yields helped lift Amazon stock, while investors appeared to refocus on the pace of AWS expansion referenced as 37%.
THE APEX TIMES
After Cisco’s latest results, Bank of America reiterated a bullish stance, saying the stock’s post-earnings setup looks stronger, while noting that a specific concern will likely determine how much further shares can rise.
THE APEX TIMES
Falling Treasury yields helped revive “speculative growth” sentiment, lifting TSLA even as investors keep circling Tesla’s profitability, with operating margin still described as the tougher hurdle.
THE APEX TIMES
A pullback in Treasury yields helped lift Apple, even as semiconductor stocks stayed under pressure in broader market trading.
THE APEX TIMES
The retailer reports second-quarter results Thursday before the market opens, with analysts focused on whether momentum can persist amid tougher comparisons and questions about the pace of improvement in margins and spending efficiency.
THE APEX TIMES
Shares of HONA surged after Morgan Stanley said the post-spinoff drop left the stock looking too cheap, even as the new aerospace operator still faces execution and transition risks.
